by Clinical Neuropsychologist | Thursday, September 5, 2024 | Neurology
No abstract available If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 5, 2024 Neurology Today – Current Issue Previous...
by Clinical Neuropsychologist | Thursday, September 5, 2024 | Neurology
No abstract available If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 5, 2024 Neurology Today – Current Issue Previous...
by Clinical Neuropsychologist | Friday, August 16, 2024 | Neurology
Background Hearing loss has been proposed as a modifiable risk factor for dementia. However, the relationship between hearing, neurodegeneration, and cognitive change, and the extent to which pathological processes such as Alzheimer’s disease and cerebrovascular...
by Clinical Neuropsychologist | Friday, August 16, 2024 | Neurology
Background Blood neurofilament light chain (NfL) is increasingly considered as a key trial biomarker in genetic frontotemporal dementia (gFTD). We aimed to facilitate the use of NfL in gFTD multicentre trials by testing its (1) reliability across labs; (2) reliability...
by Clinical Neuropsychologist | Friday, August 16, 2024 | Neurology
Background Primary progressive aphasia (PPA) defines a group of neurodegenerative disorders characterised by language decline. Three PPA variants correlate with distinct underlying pathologies: semantic variant PPA (svPPA) with transactive response DNA-binding protein...
by Clinical Neuropsychologist | Friday, August 16, 2024 | Neurology
Background Health-related quality of life (Hr-QoL) scales provide crucial information on neurodegenerative disease progression, help improve patient care and constitute a meaningful endpoint for therapeutic research. However, Hr-QoL progression is usually poorly...
